We have tested our revised Sel-MQC-CSI sequence for dependence of Lac/H2O on the B0 and B1 field inhomogeneity. The immunity of the Lac/H2O from our sequence on the above factors was demonstrated. We have improved lipid suppression from previously reported 100-fold to 22,000-fold while not losing the lactate signal. The revised sequence was applied to a glioma patient and a normal volunteer with a lactate phantom seated near the typical lymphoma occurring region of the body. In both human studies, satisfactory performance of the sequence was demonstrated.